EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® ...
Children who presented to the ED with severe asthma were eligible to enter the study. Severe asthma was classified as having all four features of respiratory distress (wheezing, sternal retraction, ...
Hosted on MSN
Pulmonologist explains the difference between acute asthma and chronic asthma: Know symptoms, treatment and more
Asthma is a major noncommunicable disease, affecting both children and adults, and is the most common chronic disease among children, as per World Health Organization (WHO). The condition affected an ...
Please provide your email address to receive an email when new articles are posted on . Risk and annualized rate of severe exacerbations dropped with as-needed use of albuterol-budesonide vs.
GlobalData on MSN
Fasenra shows benefit in acute asthma and COPD in Phase II trial
A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic exacerbations of ...
Graphs and charts don’t always tell the whole story. Numbers can be deceiving. But anyone who looks at U.S. trends in asthma mortality can see, without squinting, that things are moving in the right ...
Oral corticosteroids, although effective, pose significant adverse effects and health care costs, necessitating clear tapering guidelines and alternative treatments. Biologics significantly reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results